Membrane permeable peptide macrocycles, or nacellins, couple oral bioavailability with high affinity targeting of protein-protein interactions, including those situated inside the cell. We welcome additional opportunities to screen our library against targets of interest, particularly those intractable to small molecules. To contact us for more information on our internal activities and opportunities for collaboration.

Hookipa Biotech AG is a clinical stage biotech company aiming to develop best-in-class active immunization therapies for infectious diseases and oncology. Our proprietary TheraT and Vaxwave platforms have shown promising abilities to elicit high neutralizing antibody responses, but also necessary levels of T cell responses, currently missing in most vaccine and therapeutic approaches.

Writings about business, productivity and product management. 2017 began with a week in the backcountry of British Columbia earning my turns and appreciating the simplicity of a ski skin track, good conversation and warm food. A fantastic read and good book for the office bookshelf. I also really enjoyed reading Ski, Inc by Chris Diamond.

Connecting academia and industry to move ideas forward. Find out more about our partners. Navigating the health care funding landscape. OneStart 2016 Singapore Launch Night. OneStart 2016 London Launch Night. OneStart 2016 Oxford Launch Night.

Parallel competitions in the Americas and Europe. Open to the rest of the world as well. Experienced industry professionals from vast and storied backgrounds. Each year multiple teams go on to secure follow-on funding, not just the winner. Extensive mentoring and support to all semi-finalist teams.

At FutuRx, Johnson and Johnson Innovation JJDC, Takeda Pharmaceutical Company, through its venture group Takeda Ventures Inc. and OrbiMed Israel Partners teamed with the Office of the Chief Scientist of the Ministry of Economy in a national initiative to transform breakthrough discoveries into novel medicines by applying a unique structure of equally balanced partnership among its three founding organizations.